4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with n'-nitrosonornicotine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, S; Guengerich, FP; Hecht, SS; Koehl, W; Koenig, LA; Murphy, SE; Nunes, MG; Patten, CJ; Staretz, ME | 1 |
| Hecht, SS; McIntee, EJ; Upadhyaya, P | 1 |
| Hecht, SS; Stepanov, I | 1 |
| Carmella, SG; Han, S; Hecht, SS; Lerman, C; Pinto, A; Stepanov, I; Strasser, AA | 1 |
| Cheung, F; Errington, G; Kavvadias, D; McEwan, M; Scherer, G; Shepperd, J | 1 |
| Gao, YT; Hecht, SS; Knezevich, AD; Stepanov, I; Wang, R; Yuan, JM | 1 |
| Carmella, SG; Fernandes, P; Hatsukami, D; Hecht, SS; Khariwala, SS; Lassig, AA; Stepanov, I; Yueh, B | 1 |
| Chen, B; Hu, B; Li, XF; Qian, Y; Wu, M; Zhu, L | 1 |
| Anderson, A; Broadbent, B; Carmella, S; Hatsukami, DK; Hecht, SS; Jensen, J; Murphy, SE; Severson, H; Vogel, RI | 1 |
| Carmella, SG; Hecht, SS; Kotandeniya, D; Pillsbury, ME | 1 |
| Arnstein, S; Bernert, JT; Blount, BC; Borek, N; Brosius, C; Brown, JL; Chang, CM; Choi, D; Cobos, A; Conway, K; De Castro, BR; Edwards, KC; Ervies, G; Freeman, D; Goniewicz, ML; Guillot, T; Hatsukami, D; Hecht, SS; Hyland, A; Kimmel, HL; Lawrence, C; Lee, J; Li, Y; Nicodemus, K; Pine, BN; Van Bemmel, DM; Wade, EL; Wang, L; Xia, B; Xia, Y | 1 |
| Chaturvedi, P; Gota, V; Gurjar, M; Khariwala, SS; Nikam, SS; Patil, A; Singh, A; Singhavi, H; Stepanov, I; Villalta, P | 1 |
2 trial(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and n'-nitrosonornicotine
| Article | Year |
|---|---|
Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users.
Topics: Administration, Cutaneous; Adult; Biomarkers; Carcinogens; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Smoking; Smoking Prevention; Time Factors; Tobacco, Smokeless | 2009 |
Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
Topics: Administration, Oral; Adult; Biomarkers; Chewing Gum; Consumer Behavior; Cotinine; Female; Glucuronides; Humans; Male; Middle Aged; Minnesota; Nicotine; Nicotinic Agonists; Nitrosamines; Oregon; Pyridines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Urinalysis | 2016 |
10 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and n'-nitrosonornicotine
| Article | Year |
|---|---|
Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
Topics: Benzo(a)pyrene; Biotransformation; Carcinogens; Cytochrome P-450 Enzyme System; Humans; Microsomes, Liver; Nicotiana; Nitrosamines; Plants, Toxic | 1997 |
Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines.
Topics: Chromatography, High Pressure Liquid; Glucuronides; Magnetic Resonance Spectroscopy; Nicotiana; Nitrosamines; Plants, Toxic; Pyridines | 2001 |
Detection and quantitation of N'-nitrosonornicotine in human toenails by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Topics: Biomarkers; Carcinogens; Chromatography, Liquid; Humans; Nails; Nicotine; Nitrosamines; Pyridines; Tandem Mass Spectrometry | 2008 |
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
Topics: Carcinogens; Humans; Nicotiana; Nitrosamines; Pyridines; Smoke; Smoking | 2009 |
Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
Topics: Alcohol Drinking; Biomarkers; Carcinogens; Esophageal Neoplasms; Glucuronides; Humans; Male; Middle Aged; Nitrosamines; Prospective Studies; Pyridines; Risk; Smoking | 2011 |
Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.
Topics: Adult; Biomarkers; Carcinoma, Squamous Cell; Case-Control Studies; Creatinine; Female; Head and Neck Neoplasms; Humans; Male; Nitrosamines; Pyrenes; Pyridines; Smoking; Squamous Cell Carcinoma of Head and Neck | 2013 |
Identification of precursors and mechanisms of tobacco-specific nitrosamine formation in water during chloramination.
Topics: Alkaloids; Chloramines; Chromatography, Liquid; Drinking Water; Halogenation; Mass Spectrometry; Nicotiana; Nicotine; Nitrosamines; Pyridines; Solid Phase Extraction; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2015 |
Combined analysis of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users.
Topics: Chromatography, Liquid; Electronic Nicotine Delivery Systems; Humans; Limit of Detection; Nitrosamines; Pyridines; Reference Standards; Reproducibility of Results; Smoking; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Topics: Adolescent; Adult; Biomarkers; Carcinogens; Female; Humans; Longitudinal Studies; Male; Nitrosamines; Tobacco Use; United States; Young Adult | 2021 |
Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N'-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry.
Topics: Biomarkers; Carcinogens; Chromatography, Liquid; Cotinine; Humans; Nitrosamines; Tandem Mass Spectrometry; Tobacco Products; Tobacco Use | 2021 |